/RFCS
RFCS Stock - Refocus Group, Inc.
Healthcare|Medical - DevicesOTC
$0.00+0.00%
+$0.00 (+0.00%) • Feb 23
67
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.50
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for RFCS
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-0.58
52W High$0.00
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
Loading financial data...
Company Overview
Refocus Group, Inc., a medical device company, engages in the research and development of treatments for human vision disorders, primarily for presbyopia. The company develops VisAbility Micro-Insert System, an investigational medical device that is in clinical trials for use in the binocular presbyopic treatment. It serves patients and eye care professionals. The company was founded in 1994 and is based in Dallas, Texas.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
RFCSLoading earnings data...
Latest News
Loading news...
Frequently Asked Questions about RFCS
What is RFCS's current stock price?
Refocus Group, Inc. (RFCS) is currently trading at $0.00 per share. The stock has moved +0.00% today.
What is the analyst price target for RFCS?
No analyst price targets are currently available for this stock.
What sector is Refocus Group, Inc. in?
Refocus Group, Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the OTC exchange.
What is RFCS's market cap?
Refocus Group, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does RFCS pay dividends?
No, Refocus Group, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBUGVF
Primo Nutraceuticals Inc.
$0.00
Mkt Cap: $0.0B
GNRS
The Greenrose Holding Company Inc.
$0.00
Mkt Cap: $0.0B
GRYN
Green Hygienics Holdings Inc.
$0.00
Mkt Cap: $0.0B
LHRP
LifeHOUSE Holdings, LLC
$0.00
Mkt Cap: $0.0B
QMED
QMed, Inc.
$0.00
Mkt Cap: $0.0B
ROIX
Response Oncology, Inc.
$0.00
Mkt Cap: $0.0B
SYNI
Synvista Therapeutics, Inc.
$0.00
Mkt Cap: $0.0B
VTEQ
VeriTeQ Corporation
$0.00
Mkt Cap: $0.0B
Explore stocks similar to RFCS for comparison